WO2006059052A3 - Derives de l'inositol-phosphate et procede de detection de l'inositol-1-phosphate - Google Patents

Derives de l'inositol-phosphate et procede de detection de l'inositol-1-phosphate Download PDF

Info

Publication number
WO2006059052A3
WO2006059052A3 PCT/FR2005/051032 FR2005051032W WO2006059052A3 WO 2006059052 A3 WO2006059052 A3 WO 2006059052A3 FR 2005051032 W FR2005051032 W FR 2005051032W WO 2006059052 A3 WO2006059052 A3 WO 2006059052A3
Authority
WO
WIPO (PCT)
Prior art keywords
inositol
phosphate
ipi
study
detecting
Prior art date
Application number
PCT/FR2005/051032
Other languages
English (en)
Other versions
WO2006059052A2 (fr
Inventor
Herve Bazin
Herve Ansanay
Eric Trinquet
Gerard Mathis
Original Assignee
Cis Bio Int
Herve Bazin
Herve Ansanay
Eric Trinquet
Gerard Mathis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Bio Int, Herve Bazin, Herve Ansanay, Eric Trinquet, Gerard Mathis filed Critical Cis Bio Int
Priority to EP05824048.2A priority Critical patent/EP1817319B1/fr
Priority to JP2007543894A priority patent/JP5443689B2/ja
Priority to US11/792,135 priority patent/US8178704B2/en
Priority to ES05824048T priority patent/ES2424682T3/es
Publication of WO2006059052A2 publication Critical patent/WO2006059052A2/fr
Publication of WO2006059052A3 publication Critical patent/WO2006059052A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Abstract

La présente invention concerne des dérivés de l'inositol-phosphate, dans lesquels l'inositol-phosphate est substitué par un ou deux groupe(s) réactionnel(s) G ou une ou deux substance(s) ou molécule(s) conjuguée(s) M, ledit ou lesdits groupe(s) réactionnel(s) G ou ladite ou lesdites substance(s) ou molécule(s) M, étant lié(s) à IPl via un groupe de liaison L, M étant choisi parmi le groupe suivant : un traceur, un immunogène, un membre d'un couple de partenaires de liaison, un support solide. Application : outils permettant l'étude du cycle des inositols-phosphates et donc, indirectement, l'étude des récepteurs à sept domaines transmembranaires couplés à la phospholipase C, des récepteurs ayant une activité de tyrosine-kinase, et de manière générale des enzymes impliquées dans les variations de la concentration intracellulaire d'IPl.
PCT/FR2005/051032 2004-12-02 2005-12-02 Derives de l'inositol-phosphate et procede de detection de l'inositol-1-phosphate WO2006059052A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP05824048.2A EP1817319B1 (fr) 2004-12-02 2005-12-02 Derives de l'inositol-phosphate et procede de detection de l'inositol-1-phosphate
JP2007543894A JP5443689B2 (ja) 2004-12-02 2005-12-02 イノシトールリン酸誘導体及びイノシトール−１−リン酸の検出法
US11/792,135 US8178704B2 (en) 2004-12-02 2005-12-02 Inositol-phosphate derivatives and method of detecting inositol-1-phosphate
ES05824048T ES2424682T3 (es) 2004-12-02 2005-12-02 Derivados del inositol-fosfato y procedimiento de detección del inositol-1-fosfato

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0412797 2004-12-02
FR0412797A FR2878850B1 (fr) 2004-12-02 2004-12-02 Derives de l'inositol-1-phosphate

Publications (2)

Publication Number Publication Date
WO2006059052A2 WO2006059052A2 (fr) 2006-06-08
WO2006059052A3 true WO2006059052A3 (fr) 2006-10-05

Family

ID=34954447

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/051032 WO2006059052A2 (fr) 2004-12-02 2005-12-02 Derives de l'inositol-phosphate et procede de detection de l'inositol-1-phosphate

Country Status (6)

Country Link
US (1) US8178704B2 (fr)
EP (1) EP1817319B1 (fr)
JP (1) JP5443689B2 (fr)
ES (1) ES2424682T3 (fr)
FR (1) FR2878850B1 (fr)
WO (1) WO2006059052A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014031595A1 (fr) * 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Haptènes de palipéridone
CN107266432B (zh) * 2012-08-21 2020-05-12 詹森药业有限公司 用于免疫测定的喹硫平半抗原
CA2882615C (fr) 2012-08-21 2019-07-09 Ortho-Clinical Diagnostics, Inc. Anticorps diriges contre la quetiapine et leur utilisation
ES2935460T3 (es) 2012-08-21 2023-03-07 Janssen Pharmaceutica Nv Anticuerpos para haptenos de quetiapina y uso de los mismos
GB201311989D0 (en) * 2013-07-04 2013-08-21 Univ St Andrews Inositol biotransformation
KR101398764B1 (ko) 2013-08-29 2014-05-27 강릉원주대학교산학협력단 입자의 이동에 의해 분석물질을 검출하는 장치 및 방법
MA44067A (fr) 2015-12-17 2018-10-24 Janssen Pharmaceutica Nv Anticorps dirigés contre la quétiapine et utilisation associée
CN107132348A (zh) * 2017-02-22 2017-09-05 江苏雷森生物科技有限公司 一种彩色荧光颗粒标记抗体的方法及使用其制备的试纸条
JP6973898B2 (ja) * 2017-07-31 2021-12-01 シージェイ チェイルジェダン コーポレーションCj Cheiljedang Corporation 新規のプシコース−６−リン酸脱リン酸酵素、前記酵素を含むプシコース生産用組成物、前記酵素を利用してプシコースを製造する方法
CN109061156B (zh) * 2018-09-21 2021-07-13 中国烟草总公司郑州烟草研究院 一种检测二甲戊灵的时间分辨荧光免疫层析试纸条及其制备方法和应用
CN109061147B (zh) * 2018-09-21 2021-04-13 中国烟草总公司郑州烟草研究院 一种检测二甲戊灵的试纸条及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085740A2 (fr) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Composes et utilisations associees
US20010056072A1 (en) * 2000-05-12 2001-12-27 Manuel Martin-Lomas Compounds and their uses
WO2003087109A1 (fr) * 2002-04-12 2003-10-23 Silbiotec Due S.A. Medicaments contenant des derives de glycerophosphoinositol-4-phosphate
US20040106158A1 (en) * 2002-10-21 2004-06-03 Tabassum Naqvi IP3 protein binding assay

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570703B1 (fr) 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
FR2624862B1 (fr) 1987-12-18 1990-06-08 Oris Ind Cryptates de terres rares, procedes d'obtention, intermediaires de synthese et application a titre de marqueurs fluorescents
EP0431197A4 (en) 1989-06-28 1991-12-04 Mitsui Toatsu Chemicals Inc. Myoinositol derivative and method of production thereof, and phosphorylating agent and its use
FR2672128B1 (fr) 1991-01-28 1995-08-18 Cis Bio Int Procede de mesure de la luminescence emise dans un dosage par luminescence.
FR2680787B1 (fr) 1991-08-30 1994-11-04 Cis Bio Int Complexes macrocycliques de terres rares et leur utilisation pour reduire les interferences dans un dosage par fluorescence.
WO1996021440A1 (fr) * 1995-01-09 1996-07-18 Alpha-Therapeutics, Inc. Procedes pour accroitre la biodisponibilite d'agents ayant une activite biologique
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
GB9828565D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Inositol-containing hexasaccharidies,their synthesis and their uses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085740A2 (fr) * 2000-05-12 2001-11-15 Rodaris Pharmaceuticals Limited Composes et utilisations associees
US20010056072A1 (en) * 2000-05-12 2001-12-27 Manuel Martin-Lomas Compounds and their uses
WO2003087109A1 (fr) * 2002-04-12 2003-10-23 Silbiotec Due S.A. Medicaments contenant des derives de glycerophosphoinositol-4-phosphate
US20040106158A1 (en) * 2002-10-21 2004-06-03 Tabassum Naqvi IP3 protein binding assay

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BERLIN ET AL: "Glycosylinositol derivatives. III. Synthesis of hexosamine inositol phosphates related to putative insulin mediators", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 47, no. 1, 1991, pages 1 - 20, XP002088795, ISSN: 0040-4020 *
CHEN, JIAN ET AL: "Asymmetric Total Synthesis of Phosphatidylinositol 3-Phosphate and 4-Phosphate Derivatives", JOURNAL OF ORGANIC CHEMISTRY , 63(19), 6511-6522 CODEN: JOCEAH; ISSN: 0022-3263, 1998, XP002341242 *
COBB, JEFF E. ET AL: "Synthesis of 6-O-(2-aminoethyl)-D,L-myo-inositol 1,2-cyclic phosphate: a model of a putative insulin second messenger", TETRAHEDRON ( 1991 ), 47(1), 21 - 30 CODEN: TETRAB; ISSN: 0040-4020, 1991, XP002387812 *
COTTAZ S ET AL: "Parasite glycoconjugates. Part 3. Synthesis of substrate analogues of early intermediates in the biosynthetic pathway of glycosylphosphatidylinositol membrane anchors", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1, CHEMICAL SOCIETY. LETCHWORTH, GB, 1995, pages 1673 - 1678, XP002176135, ISSN: 0300-922X *
ESSEN L-O ET AL: "STRUCTURAL ANALYSIS OF THE CATALYSIS AND MEMBRANE ASSOCIATION OF PLC-DELTA1", ACS SYMPOSIUM SERIES, WASHINGTON, DC, US, vol. 718, 1999, pages 121 - 136, XP009051572, ISSN: 0097-6156 *
FALCK J R ET AL: "Concise syntheses of l-alpha-phosphatidyl-d-myo-inositol 3-phosphate (3-PIP), 5-phosphate (5-PIP), and 3,5-bisphosphate (3,5-PIP2)", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 41, no. 22, June 2000 (2000-06-01), pages 4271 - 4275, XP004205551, ISSN: 0040-4039 *
KRAUTER, TOBIAS ET AL: "Phospholipids as modulators of KATP channels: distinct mechanisms for control of sensitivity to sulphonylureas, K+ channel openers, and ATP", MOLECULAR PHARMACOLOGY , 59(5), 1086-1093 CODEN: MOPMA3; ISSN: 0026-895X, 2001, XP002341241 *

Also Published As

Publication number Publication date
ES2424682T3 (es) 2013-10-07
FR2878850A1 (fr) 2006-06-09
JP2008521867A (ja) 2008-06-26
FR2878850B1 (fr) 2008-10-31
JP5443689B2 (ja) 2014-03-19
US8178704B2 (en) 2012-05-15
US20080261237A1 (en) 2008-10-23
EP1817319B1 (fr) 2013-07-03
EP1817319A2 (fr) 2007-08-15
WO2006059052A2 (fr) 2006-06-08

Similar Documents

Publication Publication Date Title
WO2006059052A3 (fr) Derives de l'inositol-phosphate et procede de detection de l'inositol-1-phosphate
Qiao et al. Simultaneous extraction of enrofloxacin and ciprofloxacin from chicken tissue by molecularly imprinted matrix solid-phase dispersion
Meyer et al. Ion-pair RP-HPLC determination of sugars, amino sugars, and uronic acids after derivatization with p-aminobenzoic acid
WO2008020823A3 (fr) Systèmes de rapporteur coopératifs, composants, et procédés pour une détection d'analyte
MEP32608A (en) Antibodies to opgl
WO2006124641A3 (fr) Anticorps diriges contre la mesotheline utiles pour des dosages immunologiques
BRPI0518994A2 (pt) anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
EA200702577A1 (ru) Способ изготовления вакцин
DE602004025101D1 (de) Humane anti-humane cd3-bindungsmoleküle
WO2005052542A3 (fr) Procede et composition servant a determiner fk 506
WO2007137257A3 (fr) Système et procédé de préparation d'échantillons
MX2009006199A (es) Formulacion parenteral de anticuerpos abeta.
CA2000545A1 (fr) Procede et reactif pour la determination d'une substance pouvant etre particulierement liaisonnee
CN103157447B (zh) 高亲和力树枝状硼酸功能化磁性微球及其制备方法和应用
WO2009007846A3 (fr) Procédé pour modifier, isoler, détecter, visualiser et quantifier des peptides, polypeptides et protéines contenant de la citrulline et/ou de l'homocitrulline
WO2007067983A3 (fr) Anticorps specifique de la sulfotyrosine et utilisation a cet effet
WO2008139206A3 (fr) Agents optiques de formation d'image
WO2006031815A3 (fr) Procedes et compositions de dosages de proximite
DK1692181T3 (da) Leptinantagonist og fremgangsmåde til kvantitativ måling af leptin
WO2009003952A3 (fr) Colonne et procédé de préparation d'un échantillon biologique pour profiler une protéine
WO2003048730A3 (fr) Identification de molecules de haute affinite par depistage par dilutions limitees
WO2005124356A3 (fr) Utilisation d'une proteine cbp2 en tant que marqueur pour un cancer colorectal
BRPI0606239A2 (pt) métodos de análise de um ou mais compostos pesticidas
WO2002057739A3 (fr) Composition et procedes permettant la synthese de nouveaux traceurs pour detecter l'amphetamine et la methamphetamine dans des echantillons
Theodoridis Application of solid-phase microextraction in the investigation of protein binding of pharmaceuticals

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2007543894

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005824048

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 2005824048

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11792135

Country of ref document: US